Prodeon Medical, Inc

BPH Relief, Simplified.

[Prodeon Medical, Inc @Prodeonmedical]

Prodeon Medical announced the completion of patient enrollment for the Expander-2 Pivotal Trial, a study evaluating the Urocross Expander System for minimally invasive treatment of Lower Urinary Tract Symptoms (LUTS) due to Benign Prostatic Hyperplasia (BPH). https://t.co/I4KRG9UD9c

[Prodeon Medical, Inc @Prodeonmedical]

Prodeon will attend The MedTech Conference in Toronto from October 15-17, 2024!

This event brings together over 3,500 attendees and features more than 100 sessions covering everything from digital health to AI in healthcare. Plus, with 400+ speakers and cutting-edge exhibitors, it’s the place to be if you want to stay ahead in the medtech world.

Don’t miss this chance to network, learn, and discover the latest innovations shaping the future of healthcare. We'll be there, and we hope to see you too!

Register now! https://t.co/VrnqEy7B9l

#MedTechCon #MTC24